dihexa chemical properties solubility stability formulation | Peptide Synthetic | High Purity DIHEXA 30ML LIQUID (20MG/ML, 600MG

These peptides are not FDA-approved for disease treatment and are intended for research and educational purposes

Side effect comparison by dose tier Side effects are not random

BPC-157 fits none of those today

For example, one study conducted by Vogiatzoglou and colleagues shows that, when tHcy and MMA reached their breakpoints of 334 and 393 pmol/L respectively as defined as B12 replete, the B12 levels were 400 pmol/L.8 Another study by Selhub and colleagues shows similar results and suggests that tHcy and MMA, as metabolic markers, may replace or augment B12 level in the diagnosis of B12 deficiency.5 In a clinical trial of determining the relationship between the treatment effect and tHcy levels on brain atrophy over 2 years, half of the participants were treated with B12, B6 and folic acid to lower their tHcy levels.9 Results showed that brain atrophy was slowed by 30% compared to placebo, tHcy was lower by 30%, and plasma B12 was raised from 330 to 672 pmol/L

Meet with our provider in-office or through secure telehealth

This type of exercise appears to stimulate beneficial remodeling of damaged tendon tissue and can complement BPC-157s biochemical effects